1-9 of 9
Harlan Robins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma

Erik Yusko, Marissa Vignali, Richard K. Wilson, Elaine R. Mardis, F. Stephen Hodi, Christine Horak, Han Chang, David M. Woods, Harlan Robins, Jeffrey Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (3): 458–465.
https://doi.org/10.1158/2326-6066.CIR-18-0226
Published: 01 March 2019
View article titled, Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma
Open the PDF for Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma in another window
Includes: Supplementary data
Journal Articles

Abstract B115: Optimization of cancer vaccine development by using Multiplexed Identification of T-cell Receptor Antigen specificity (MIRA)

Peter Ebert, Mark Klinger, Edward Osborne, Ruth Taniguchi, Joyce Hu, Tim Hayes, Sharon Benzeno, Adria Carbo, Melanie Laur, Erica Eggers, Harlan Robins
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): B115.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-B115
Published: 01 February 2019
View article titled, Abstract B115: Optimization of cancer vaccine development by using Multiplexed Identification of T-cell Receptor Antigen specificity (MIRA)
Journal Articles

Abstract A034: High-throughput identification of naturally occurring T-cell receptors with therapeutic potential against tumor-associated, viral and neoantigens

Mark Klinger, Peter Ebert, Edward Osborne, Ruth Taniguchi, Joyce Hu, Tim Hayes, Sharon Benzeno, Adria Carbo, Melanie Laur, Erica Eggers, Harlan Robins
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): A034.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A034
Published: 01 February 2019
View article titled, Abstract A034: High-throughput identification of naturally occurring T-cell receptors with therapeutic potential against tumor-associated, viral and neoantigens
Journal Articles

Abstract A51: High-throughput method identifies rare, high-affinity, thymus-vetted T cell receptors (TCRs) for clinical translation

Thomas M. Schmitt, Megan McAfee, Harlan Robins, Lara Kropp, Philip D. Greenberg, Aude G. Chapuis
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (9_Supplement): A51.
https://doi.org/10.1158/2326-6074.TUMIMM17-A51
Published: 01 September 2018
View article titled, Abstract A51: High-throughput method identifies rare, high-affinity, thymus-vetted T cell receptors (TCRs) for clinical translation
Journal Articles

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

Charlotte E. Ariyan, Mary Sue Brady, Robert H. Siegelbaum, Jian Hu, Danielle M. Bello, Jamie Rand, Charles Fisher, Robert A. Lefkowitz, Kathleen S. Panageas, Melissa Pulitzer, Marissa Vignali, Ryan Emerson, Christopher Tipton, Harlan Robins, Taha Merghoub, Jianda Yuan, Achim Jungbluth, Jorge Blando, Padmanee Sharma, Alexander Y. Rudensky, Jedd D. Wolchok, James P. Allison
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2018) 6 (2): 189–200.
https://doi.org/10.1158/2326-6066.CIR-17-0356
Published: 31 January 2018
View article titled, Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade
Open the PDF for Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade in another window
Includes: Supplementary data
Journal Articles

Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis

Rajeev K. Shrimali, Shamim Ahmad, Vivek Verma, Peng Zeng, Sudha Ananth, Pankaj Gaur, Rachel M. Gittelman, Erik Yusko, Catherine Sanders, Harlan Robins, Scott A. Hammond, John E. Janik, Mikayel Mkrtichyan, Seema Gupta, Samir N. Khleif
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2017) 5 (9): 755–766.
https://doi.org/10.1158/2326-6066.CIR-17-0292
Published: 31 August 2017
View article titled, Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Open the PDF for Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis in another window
Includes: Supplementary data
Journal Articles

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth, Erik Yusko, Yaomin Xu, Xingyi Guo, Riley C. Ennis, David Fabrizio, Zachary R. Chalmers, Joel Greenbowe, Siraj M. Ali, Sohail Balasubramanian, James X. Sun, Yuting He, Dennie T. Frederick, Igor Puzanov, Justin M. Balko, Justin M. Cates, Jeffrey S. Ross, Catherine Sanders, Harlan Robins, Yu Shyr, Vincent A. Miller, Philip J. Stephens, Ryan J. Sullivan, Jeffrey A. Sosman, Christine M. Lovly
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11): 959–967.
https://doi.org/10.1158/2326-6066.CIR-16-0143
Published: 31 October 2016
View article titled, Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Open the PDF for Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade in another window
Includes: Supplementary data
Journal Articles

Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy

David B. Page, Jianda Yuan, David Redmond, Y Hanna Wen, Jeremy C. Durack, Ryan Emerson, Stephen Solomon, Zhiwan Dong, Phillip Wong, Christopher Comstock, Adi Diab, Janice Sung, Majid Maybody, Elizabeth Morris, Edi Brogi, Monica Morrow, Virgilio Sacchini, Olivier Elemento, Harlan Robins, Sujata Patil, James P. Allison, Jedd D. Wolchok, Clifford Hudis, Larry Norton, Heather L. McArthur
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (10): 835–844.
https://doi.org/10.1158/2326-6066.CIR-16-0013
Published: 02 October 2016
View article titled, Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy
Open the PDF for Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor

Anna Pasetto, Alena Gros, Paul F. Robbins, Drew C. Deniger, Todd D. Prickett, Rodrigo Matus-Nicodemos, Daniel C. Douek, Bryan Howie, Harlan Robins, Maria R. Parkhurst, Jared Gartner, Katarzyna Trebska-McGowan, Jessica S. Crystal, Steven A. Rosenberg
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (9): 734–743.
https://doi.org/10.1158/2326-6066.CIR-16-0001
Published: 01 September 2016
View article titled, Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
Open the PDF for Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor in another window
Includes: Supplementary data